About Shenandoah Biotechnology
Shenandoah Biotechnology is a Healthcare company based in Horsham (United States) founded in 2006, and was acquired by Irvine Scientific in March 2022. Cytokines and recombinant proteins for research. Its chief executive, as recorded, is Pamela De Lacy. Shenandoah Biotechnology offers products and services including BalanCD CHO Media, PRIME-XV Media, Recombinant Proteins, and Custom Media Services. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its competitors include PrognomiQ, List Biological Laboratories and ACRO Biosystems; 2 of its 3 listed competitors have raised funding.
Company details
Shenandoah Biotechnology manufactures and supplies cytokines and recombinant protein products for research applications. The company specializes in the manufacture of recombinant proteins from E.coli, with their current product line mainly focused on recombinant cytokines, chemokines and growth factors typically used in a wide variety of research applications.
- Headquarters Horsham, United States
- Stage Acquired
- SectorsHealthcare
- Website shenandoah-bt.com
- Social LinkedIn X
- Acquired by Irvine Scientific (Mar 2022)
- Investors
- Acquired byIrvine Scientific
(Mar 2022)
Products & Services of Shenandoah Biotechnology
Shenandoah Biotechnology offers a comprehensive portfolio of products and services, including BalanCD CHO Media, PRIME-XV Media, Recombinant Proteins, and Custom Media Services.
Media for CHO cell culture in bioprocessing applications.
Media for immune and stem cell culture processes.
Proteins for research and therapeutic applications.
Tailored media optimization for specific needs.
Investors in Shenandoah Biotechnology
Shenandoah Biotechnology has secured backing from 1 investor. Prominent investors backing the company include Irvine Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Manufacture of cell culture media, reagents, and medical devices for researchers and clinicians | 1970 | irvinesci.com | Santa Ana, United States |
Investor details for Shenandoah Biotechnology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Shenandoah Biotechnology
1 people are tracked at Shenandoah Biotechnology (1 in leadership).
| Name | Role | Group |
|---|---|---|
Pamela De Lacy | President & CEO | Leadership |
Complete people profiles for Shenandoah Biotechnology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Shenandoah Biotechnology
2 dated milestones of Shenandoah Biotechnology across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Shenandoah Biotechnology is founded.
- Exit Acquired by Irvine Scientific.
Competitors of Shenandoah Biotechnology
Shenandoah Biotechnology has 3 listed competitors in our database, 2 of them funded. They include PrognomiQ, List Biological Laboratories and ACRO Biosystems.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| prognomiq.com | 2020 | San Mateo, United States | $90.36M | 24 | Developer of tests for the detection and treatment of cancer and other diseases | |
| listlabs.com | 1978 | Campbell, United States | $48.4M | Specializes in the production of research reagents | ||
| acrobiosystems.com | 2016 | Newark, United States | 22 | Recombinant proteins are manufactured to support cancer immunotherapy efforts. |
Detailed competitors of Shenandoah Biotechnology
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Shenandoah Biotechnology
Websites that share an audience with Shenandoah Biotechnology (shenandoah-bt.com).
Websites whose visitors overlap most with Shenandoah Biotechnology. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| invivogen.com | 100% | #465,301 | View details | ||
| raybiotech.com | 96% | 71.1K | #537,358 | View details | |
carcinoembryonic-antigen.de | carcinoembryonic-antigen.de | 96% | – | ||
parkbio.com | parkbio.com | 96% | – | ||
| novusbio.com | 93% | 199.6K | #232,152 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Shenandoah Biotechnology
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Shenandoah Biotechnology (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Shenandoah Biotechnology
Shenandoah Biotechnology was founded in 2006.
Shenandoah Biotechnology is headquartered in Horsham, United States. It is registered at Horsham, Pennsylvania, United States.
Pamela De Lacy is the CEO of Shenandoah Biotechnology, as recorded in our data.
Shenandoah Biotechnology manufactures and supplies cytokines and recombinant protein products for research applications. The company specializes in the manufacture of recombinant proteins from E.coli, with their current product line mainly focused on recombinant cytokines, chemokines and growth factors typically used in a wide variety of research applications.
Shenandoah Biotechnology's top competitors include PrognomiQ, ACRO Biosystems and List Biological Laboratories.
Shenandoah Biotechnology offers BalanCD CHO Media, PRIME-XV Media, Recombinant Proteins, and Custom Media Services.
Shenandoah Biotechnology has 1 investor. Key investors include Irvine Scientific.
Yes. Shenandoah Biotechnology was acquired by Irvine Scientific in March 2022.